These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8926874)

  • 61. [Immunomorphologic reactions following aerosol and subcutaneous immunization of animals with live dry anthrax vaccines].
    Suchkova TI; Shul'man-Satin BB
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):85-90. PubMed ID: 5511393
    [No Abstract]   [Full Text] [Related]  

  • 62. [Sensitization by repeated skin tests with candidin and PHA].
    Leynadier F; Jousset D; Noirot C; Bouderlique JR; Dry J
    Pathol Biol (Paris); 1984 Nov; 32(9):954-8. PubMed ID: 6504572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Experimental immunization with live anthrax STI vaccine using a needleless injector].
    Saltykov RA; Nekrasov IL; Lesniak OT; Ulanova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 May; 48(5):52-5. PubMed ID: 5560807
    [No Abstract]   [Full Text] [Related]  

  • 64. [Encephalitis developing after vaccination without a local skin reaction].
    Naumova RP; Andriĭchenko NV
    Vrach Delo; 1979 Jul; (7):114-5. PubMed ID: 473733
    [No Abstract]   [Full Text] [Related]  

  • 65. [Postvaccinal complications].
    Ptashka EM
    Feldsher Akush; 1980; 45(1):10-5. PubMed ID: 6444594
    [No Abstract]   [Full Text] [Related]  

  • 66. [Immunization against anthrax by a needleless method].
    Burgasov PN; Cherkasskiĭ BL; Adilov DA; Knop AG; Savinykh AI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):23-6. PubMed ID: 4784586
    [No Abstract]   [Full Text] [Related]  

  • 67. [Remote hyperergic-allergic reactions of the skin following tularemia vaccination].
    Pototskiĭ II
    Vestn Dermatol Venerol; 1967 Feb; 41(2):81-2. PubMed ID: 5620485
    [No Abstract]   [Full Text] [Related]  

  • 68. Molecular profiling of skin test-induced inflammation to support the clinical diagnosis of delayed drug hypersensitivity reaction.
    Mosnier A; Vocanson M; Lefevre MA
    Eur J Dermatol; 2023 Feb; 33(1):64-66. PubMed ID: 37178043
    [No Abstract]   [Full Text] [Related]  

  • 69. A Rare Case of Delayed Hypersensitivity Following COVID-19 Booster Necessitating Treatment With Dupilumab.
    Hanoodi M; Logee DO K
    Cureus; 2023 Apr; 15(4):e37544. PubMed ID: 37193457
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Epidemiologic effectiveness of anthrax vaccine STI].
    Burgasov PN; Cherkasskiĭ BL; Knop AG; Utegenov KU
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):27-35. PubMed ID: 1015076
    [No Abstract]   [Full Text] [Related]  

  • 71. [SKIN ALLERGY TEST WITH ANTHRAXIN IN PERSONS VACCINATED AGAINST MALIGNANT PUSTULE BY DIFFERENT METHODS].
    SLIAHOV EN
    Microbiol Parazitol Epidemiol (Bucur); 1963; 8():69-79. PubMed ID: 14047910
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pronounced reaction after vaccination against tularemia].
    Koldoba LG; Rudenko MI
    Vrach Delo; 1969 May; 5():116-7. PubMed ID: 5368854
    [No Abstract]   [Full Text] [Related]  

  • 73. Hazards of immunisation.
    Lancet; 1967 Aug; 2(7513):456-7. PubMed ID: 4166113
    [No Abstract]   [Full Text] [Related]  

  • 74. [Dynamics of immuno-allergic and morphological reactions in experimental anthrax vaccination].
    Shliakhov EN; Shroĭt IG; Burdenko TA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Mar; 42(3):106-11. PubMed ID: 5882762
    [No Abstract]   [Full Text] [Related]  

  • 75. [Undesired late complications following Isomucase injections].
    Hellenbroich DO
    Z Haut Geschlechtskr; 1972 Apr; 47(8):391-4. PubMed ID: 5052002
    [No Abstract]   [Full Text] [Related]  

  • 76. To promote vaccination, physicians need to provide booster shots of information.
    Picard A
    Paediatr Child Health; 2015 Mar; 20(2):65-6. PubMed ID: 25838775
    [No Abstract]   [Full Text] [Related]  

  • 77. [Delayed hypersensitivity in man after booster anthrax vaccination].
    Shlyakhov E; Rubinstein E
    Med Trop (Mars); 1996; 56(2):148-50. PubMed ID: 8926874
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Post anthrax vaccine delayed hypersensitivity. II--delayed hypersensitivity in humans vaccinated against anthrax].
    Shlyakhov E; Rubinstein E
    Med Trop (Mars); 1994; 54(2):133-6. PubMed ID: 7934778
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Delayed hypersensitivity after anthrax vaccination. I--Study of guinea pigs vaccinated against anthrax].
    Shlyakhov E; Rubinstein E
    Med Trop (Mars); 1994; 54(1):33-7. PubMed ID: 8196523
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers.
    Laurichesse H; Gourdon F; Smits HL; Abdoe TH; Estavoyer JM; Rebika H; Pouliquen P; Catalina P; Dubray C; Beytout J
    Clin Microbiol Infect; 2007 Apr; 13(4):395-403. PubMed ID: 17359323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.